Allergic rhinitis: broader disease effects and implications for management.
Allergic rhinitis is a burdensome disease for a significant part of the population in both adults and children. Poorly controlled allergic rhinitis can trigger exacerbations of asthma, sinusitis, and otitis media, diseases with which it shares common pathophysiologic elements. Consequently, early diagnosis and treatment should be a priority for patients and physicians, not only to control the symptoms of allergic rhinitis but also to improve the management of associated diseases. Several pharmacologic therapies can be considered in an armamentarium that includes antihistamines (intranasal and systemic), intranasal cromolyn, intranasal anticholinergic agents, intranasal steroids, systemic steroids, immunotherapy, and, most recently, leukotriene receptor antagonists. Often, combinations of these treatments are used to maximize control of refractory symptoms.
Baroody
Fuad M
FM
Section of Otolaryngology and Head and Neck Surgery, Pritzker School of Medicine, The University of Chicago, Illinois, USA. fbaroody@surgery.bsd.uchicago.edu
D000328:Adult; D001249:Asthma / Q000453:epidemiology / Q000628:therapy; D002648:Child; D015897:Comorbidity; D017281:Cost of Illness; D006801:Humans; D018836:Inflammation Mediators / Q000276:immunology; D010033:Otitis Media / Q000453:epidemiology / Q000628:therapy; D012221:Rhinitis, Allergic, Perennial / Q000453:epidemiology / Q000276:immunology / Q000503:physiopathology*; D006255:Rhinitis, Allergic, Seasonal / Q000453:epidemiology / Q000276:immunology / Q000503:physiopathology*; D012852:Sinusitis / Q000453:epidemiology / Q000628:therapy
D018836:Inflammation Mediators